What is Reviva Pharmaceuticals Holdings Inc.?
, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.01M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.